Known for its incredible diversity, stunning landscapes and rich culture, South Africa (Afrigen Biologics (Pty) Ltd) is also a part of the world wide mRNA Tech Transfer Hub Programme. Institute
Read FullSouth African President Cyril Ramaphosa has welcomed Belgium’s King Philippe and Queen Mathilda to the capital Pretoria, lauded the European country for its assistance to Africa during the COVID-19 pandemic
Read FullThe first activity of the business delegation was a networking lunch organized by the Belgian Chamber of Commerce for Southern Africa in Cape Town, Wallonia Export & Investment Agency, hub.brussels and Flanders Investment & Trade
Read FullPress release: visit of His Majesty the King of the Belgians Philippe and Her Majesty the Queen of the Belgians Mathilde to Afrigen Biologics Belgian Royal delegation visits the Afrigen
Read FullPress release: Cape Town-based biotechnology company, Afrigen, appoints new board chair
Read FullAcademics have a key role to play in enhancing the impacts of public–private partnerships as demonstrated so clearly by the response to COVID-19, a panel of experts agreed during the
Read FullProvides training for about 40 Afrigen personnel on overall biopharmaceutical production as part of GTH-B program.
Read FullSouth Africa’s Afrigen Biologics has an innovative partnership with Belgian group, Univercells, which is paving the way for the development of the first African-owned mRNA COVID-19 vaccine. It could provide
Read FullBy 2040, the African Union aims to locally produce 60% of vaccines needed on the continent. In support of this goal, PQM+ is collaborating with AUDA-NEPAD, South African Health Products
Read FullAgribiomed (ABM) Africa has secured an exclusive license for Afrigen’s proprietary encapsulation technology for Cannabidiol (CBD) oil in the EU, UK and EEC. The technology makes CBD water soluble, and
Read Full